万维提示:
1、投稿方式:在线投稿。
2、官网网址:
https://www.journals.elsevier.com/genes-and-diseases
3、投稿网址:https://www.editorialmanager.com/GENDIS
4、官网邮箱:editor@genesndiseases.com(编辑部)
5、官网电话:023-65714691(编辑部)
6、出刊日期:双月刊,逢单月出版。
2021年8月30日星期一
《基因与疾病(英文)》投稿指南
【官网信息】
Guide for Authors
About the Journal
Genes & Diseases is an international journal for molecular and translational medicine. The journal primarily focuses on publishing investigations on the molecular bases and experimental therapeutics of human diseases. Publication formats include full length research article, review article, short communication, correspondence, perspectives, commentary, views on news, research watch, letters, research highlights, and enabling and emerging technologies.
Aims and Scope
Genes & Diseases publishes rigorously peer-reviewed and high quality original articles and authoritative reviews that focus on the molecular bases of human diseases. Emphasis will be placed on hypothesis-driven, mechanistic studies relevant to pathogenesis and/or experimental therapeutics of human diseases. The journal has worldwide authorship, and a broad scope in basic and translational biomedical research of molecular biology, molecular genetics, and cell biology, including but not limited to cell proliferation and apoptosis, signal transduction, stem cell biology, developmental biology, gene regulation and epigenetics, cancer biology, immunity and infection, neuroscience, disease-specific animal models, gene and cell-based therapies, and regenerative medicine.
Editorial Process
All manuscripts received are duly acknowledged. Upon submission, the Editorial Office will check the manuscript's conformity to technical quality and author guidelines, typically within one week. Manuscripts with insufficient conformity are returned to authors for revision. Manuscripts with insufficient originality, serious scientific or experimental flaws, or lack of interest to the readership of Genes & Diseases will be rejected by the Editor-in-Chief and/or Deputy Editor-in-Chief without further peer review. Manuscripts deemed suitable for publication are sent to the Executive Associate Editors. The Executive Associate Editors will make initial assessment and will serve as the managing editor, who in turn will appoint 2-3 editorial board members and/or external referees to complete peer reviews within 4 weeks. Based on the recommendations and comments made by peer reviewers, the Executive Associate Editor will make a formal recommendation to the Editor-in-Chief and/or Deputy Editor-in-Chief who will make the final decision within 1 week, in consultation with other editorial board members, if deemed necessary. The comments and recommendations (acceptance/ rejection/ minor revision/ major revision in manuscript) received from reviewers are conveyed to the corresponding author. If necessary, the author is required to provide a point by point response to reviewers' comments and submit a revised manuscript. This process will be repeated till reviewers and editors are satisfied with the revised manuscript.
Manuscripts accepted for publication are copy edited for grammar, punctuation, print style, and format. Page proofs are sent to the corresponding author. The corresponding author is expected to return the corrected proofs within 48 hours. The whole process of submission of the manuscript, final decision, sending and receiving proofs is completed online. To achieve faster and greater dissemination of knowledge and information, the journal publishes articles online as 'Ahead of Print' immediately upon acceptance.
During submission, the contributor is requested to provide names of at least three qualified reviewers who have had experience in the subject of the submitted manuscript. The reviewers should not be affiliated with the same institutes as the contributor/s. However, the selection of these reviewers is at the sole discretion of the editor.
Contact Details for Submission
Papers should be submitted through the Genes & Diseases online submission system, https://www.editorialmanager.com/GENDIS. For questions on the submission and reviewing process, please contact the Editorial Office at: editor@genesndiseases.com; telephone +86-23-6571 4691.
……
更多详情请查看期刊官网信息:
https://www.elsevier.com/journals/genes-and-diseases/2352-3042/guide-for-authors